Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pfizer

23.12
-0.2700-1.15%
Post-market: 23.140.0198+0.09%19:59 EDT
Volume:33.20M
Turnover:770.91M
Market Cap:131.45B
PE:16.71
High:23.44
Open:23.44
Low:23.08
Close:23.39
Loading ...

Pfizer Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
9 hours ago

Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis

Motley Fool
·
Yesterday

Here Are All 6 Stocks I've Bought Through 5 Months of 2025

Motley Fool
·
Yesterday

Basilea Pharmaceutica AG and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China

Reuters
·
Yesterday

Pfizer management to meet with Piper Sandler

TIPRANKS
·
Yesterday

How Moderna Went From Pandemic Hero to Vaccine Victim -- WSJ

Dow Jones
·
03 Jun

Analysts Conflicted on These Healthcare Names: Pfizer (PFE), Sagimet Biosciences, Inc. Class A (SGMT) and Janux Therapeutics Inc (JANX)

TIPRANKS
·
03 Jun

3 Safe Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 11.35% -- That Make for No-Brainer Buys in June

Motley Fool
·
03 Jun

Arvinas-Pfizer partnership dynamics may shift, says H.C. Wainwright

TIPRANKS
·
02 Jun

Pfizer CEO to Speak at Goldman Sachs Global Healthcare Conference

Reuters
·
02 Jun

Bernstein Keeps Their Hold Rating on Pfizer (PFE)

TIPRANKS
·
02 Jun

Arvinas, Pfizer announce VERITAC-2 trial did not reach statistical significance

TIPRANKS
·
02 Jun

Terrible News for Pfizer Stock Investors

Motley Fool
·
01 Jun

Arvinas Inc - Vepdegestrant First Protac to Show Benefit in Breast Cancer

THOMSON REUTERS
·
31 May

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients With Esr1-Mutant, Er+/Her2- Advanced Breast Cancer

THOMSON REUTERS
·
31 May

Arvinas Inc - Nda for Vepdegestrant to Be Submitted to FDA in Second Half of 2025

THOMSON REUTERS
·
31 May

Arvinas Inc - Vepdegestrant Well Tolerated With Low Gi Adverse Events

THOMSON REUTERS
·
31 May

Pfizer-Arvinas breast cancer drug tops AstraZeneca's in delaying progression

Reuters
·
31 May

US CDC keeps recommendation of COVID vaccines for healthy kids, report says

Reuters
·
31 May

U.S. Cdc Keeps Covid Vaccine Recommendation for Kids, Contradicting Health Secretary -Washington Post

THOMSON REUTERS
·
31 May